Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Pathological complete response after neoadjuvant pembrolizumab and radiationSeminars in Neonatology..  44:570-573. 2019
2018 Molecular determinants of post-mastectomy breast cancer recurrencenpj Breast Cancer.  4. 2018
2018 Breast Cancer Screening and Optimizing RecommendationsSeminars in Roentgenology.  53:280-293. 2018
2018 Contrast-Enhanced Spectral Mammography in Breast ImagingSeminars in Roentgenology.  53:294-300. 2018
2018 High-Risk Breast Lesions and Current ManagementSeminars in Roentgenology.  53:252-260. 2018
2018 Post-mastectomy Radiation Yes but Internal Mammary Nodes NoInternational Journal of Radiation Oncology - Biology - Physics.  102:285-286. 2018
2018 A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivorsBasic Research in Cardiology, Supplement.  124:3427-3435. 2018
2018 The Evolving Role of Postmastectomy Radiation TherapySurgical Clinics of North America.  98:801-817. 2018
2018 Pilot Randomized Controlled Trial of a Home Vegetable Gardening Intervention among Older Cancer Survivors Shows Feasibility, Satisfaction, and Promise in Improving Vegetable and Fruit Consumption, Reassurance of Worth, and the Trajectory of Central AdiposityJournal of the Academy of Nutrition and Dietetics.  118:689-704. 2018
2018 Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastasesJournal of Cutaneous Pathology.  45:48-53. 2018
2018 Innovations in Personalized and Targeted Therapies for Breast CancerInternational Journal of Breast Cancer.  2018. 2018
2018 Postmastectomy Radiation Therapy: Are We Ready to Individualize Radiation?International Journal of Breast Cancer.  2018. 2018
2017 Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical TrialsAnnual review of pharmacology.  24:2855-2862. 2017
2017 Eliminating Surgery in Early-Stage Breast Cancer: Pipe-Dream or Worthy Consideration in Selected Patients?Hospital Pharmacy.  9:148-155. 2017
2017 Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on national membership survey by the American Society for Radiation Oncology (ASTRO)Practical Radiation Oncology.  7:113-119. 2017
2017 Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy.Journal of Historical Research in Marketing.  7:14. 2017
2016 Radiotherapy to Control Limited Melanoma Progression Following IpilimumabJournal of Immunotherapy.  39:373-378. 2016
2016 Detailed methods of two home-based vegetable gardening intervention trials to improve diet, physical activity, and quality of life in two different populations of cancer survivorsJournal of receptor research.  50:201-212. 2016
2016 US radiation oncology practice patterns for posttreatment survivor carePractical Radiation Oncology.  6:50-56. 2016
2015 Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenariosPractical Radiation Oncology.  5:e557-e565. 2015
2015 TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancerCurrent Obesity Reports.  21:2722-2729. 2015
2015 Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trialsJournal of Drugs in Dermatology.  26:239-241. 2015
2015 Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis: Mukesh MB, Barnett GC, Wilkinson JS, et al (Cambridge Univ Hosps Natl Health Service Foundation Trust, UK; Et al) J Clin Oncol 31:4488-4495, 2013Journal of Drugs in Dermatology.  26:76-78. 2015
2015 Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017Annual review of pharmacology.  22:75-81. 2015
2015 Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013Journal of Drugs in Dermatology.  26:243-245. 2015
2014 Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanomaMelanoma Research.  25:246-251. 2014
2014 IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: Long term results of an ISIORT pooled analysis: Fastner G, Sedlmayer F, Merz F, et al (Paracelsus Med Univ, Salzburg, Austria; Et al) Radiother Oncol 108:279-286, 2013Journal of Drugs in Dermatology.  25:170-171. 2014
2013 Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost: Chadha M, Woode R, Sillanpaa J, et al (Beth Israel Med Ctr, NY) Int J Radiat Oncol Biol Phys 86:40-44, 2013Journal of Drugs in Dermatology.  24:386-388. 2013
2013 Multimodality therapy for high-risk endometrial cancer: Balancing the courses while keeping all options on the tableOncology.  27. 2013
2013 Image guided radiation therapy (IGRT) technologies for radiation therapy localization and deliveryInternational Journal of Radiation Oncology - Biology - Physics.  87:33-45. 2013
2013 Harvest for health gardening intervention feasibility study in cancer survivorsJournal of Neonatology.  52:1110-1118. 2013
2013 MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer: Bufi E, Belli P, Costantini M (Catholic Univ, Rome, Italy) Br J Radiol 85:e995-e1003, 2012Journal of Drugs in Dermatology.  24:177-179. 2013
2013 Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017Basic Research in Cardiology, Supplement.  119:1776-1783. 2013
2013 Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer; The university of alabama at birmingham experienceInternational Journal of Gynecological Cancer.  23:559-566. 2013
2013 Accelerated partial breast irradiation for early-stage breast cancer: Controversies and current indications for usePrimary cardiology.  14:51-65. 2013
2012 Ductal carcinoma in situ with microinvasion: Prognostic implications, long-term outcomes, and role of axillary evaluationJournal of Drugs in Dermatology.  23:254-257. 2012
2012 Image-based 3D treatment planning for vaginal cylinder brachytherapy: Dosimetric effects of bladder filling on organs at riskInternational Journal of Radiation Oncology - Biology - Physics.  83:980-985. 2012
2012 Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration: Gnerlich JL, Deshpande AD, Jeffe DB, et al (Washington Univ School of Medicine, St Louis, MO; Saint Louis Univ School of Public Health, MO) Ann Surg Oncol 18:1837-1844, 2011Journal of Drugs in Dermatology.  23:138-140. 2012
2012 American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomyIn M. Stanhope & J. Lancater (Eds.) Community health nursing: Process and practice for promoting health.  11:58-67. 2012
2012 American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancerIn M. Stanhope & J. Lancater (Eds.) Community health nursing: Process and practice for promoting health.  11:68-75. 2012
2012 American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapyIn M. Stanhope & J. Lancater (Eds.) Community health nursing: Process and practice for promoting health.  11:47-52. 2012
2011 Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?: Daveau C, Savignoni A, Abrous-Anane S, et al (Institut Curie, Paris, France) Int J Radiat Oncol Biol Phys 79:1452-1459, 2011Journal of Drugs in Dermatology.  22:402-404. 2011
2011 An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events.Journal of Clinical Oncology.  29:121. 2011
2011 Precise correlation between MRI and histopathology - Exploring treatment margins for MRI-guided localized breast cancer therapy: Schmitz AC, van den Bosch MAAJ, Loo CE, et al (Antoni van Leeuwenhoek Hosp (NKI-AVL), Amsterdam, the Netherlands; Univ Med Ctr Utrecht, the Netherlands; et al) Radiother Oncol 97:225-232, 2010Journal of Drugs in Dermatology.  22:204-205. 2011
2011 Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.Journal of Clinical Oncology.  29:e11048. 2011
2011 Nanoparticle-enhanced MRI to evaluate radiation delivery to the regional lymphatics for patients with breast cancerJournal of Drugs in Dermatology.  22:74-75. 2011
2011 Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancerInternational Journal of Radiation Oncology - Biology - Physics.  79:348-355. 2011
2011 Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapyTrends in Neurosciences.  11:312-319. 2011
2010 The importance and evolution of radiation dose in DCISParallel Algorithms and Applications.  6:249-255. 2010
2010 Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancerTrends in Neurosciences.  10:275-280. 2010
2010 Effects of Bladder Distension on Organs at Risk in 3D Image-Based Planning of Intracavitary Brachytherapy for Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics.  76:485-489. 2010
2008 Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics.  71:428-434. 2008
2008 An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignanciesMedical Dosimetry.  33:71-77. 2008
2007 In Reply To Dr. Heyman et al.International Journal of Radiation Oncology - Biology - Physics.  69:1650-1651. 2007
2007 A Dosimetric Comparison of Electronic Compensation, Conventional Intensity Modulated Radiotherapy, and Tomotherapy in Patients With Early-Stage Carcinoma of the Left BreastInternational Journal of Radiation Oncology - Biology - Physics.  68:1505-1511. 2007
2007 Anemia correction in malignancy management: Threat or opportunity?Gynecologic Oncology.  105:517-529. 2007
2006 An IMRT technique to increase therapeutic ratio of breast irradiation in patients with early stage left breast cancer: Limiting second malignancies.Journal of Clinical Oncology.  24:10791. 2006
2006 Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experienceIn M. Stanhope & J. Lancater (Eds.) Community health nursing: Process and practice for promoting health.  5:49-55. 2006
2005 Simultaneous optimization of sequential IMRT plansMedical Physics.  32:3257-3266. 2005
2004 IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at riskInternational Journal of Radiation Oncology - Biology - Physics.  60:505-512. 2004
2004 The role of amifostine in the treatment of carcinoma of the uterine cervix: An update of RTOG-0116 and review of future directionsSeminars in Oncology.  31:37-41. 2004
2002 Epidermal growth factor receptor as a therapeutic target in head and neck cancerSeminars in Radiation Oncology.  12:11-20. 2002
2000 Carcinoma of the male breast.Primary cardiology.  1:221-227. 2000
1997 Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institutionInternational Journal of Radiation Oncology - Biology - Physics.  38:3-8. 1997

Investigator On

  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2019 - 2025
  • Harvest for Health in Older Cancer Survivors  awarded by National Cancer Institute/NIH/DHHS 2016 - 2021
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect  awarded by University of Wisconsin-Madison 2016 - 2019
  • XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)  awarded by University of Wisconsin-Madison 2016 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2016 - 2018
  • Private Grant  awarded by Novartis Pharma AG 2014 - 2017
  • Prospective Study of MRI and Multi-Parameter Gene Expression Assay in Ductal Carcinoma in Situ (DCIS) (R15-037)  awarded by American College of Radiology Imaging Network 2015 - 2017
  • Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors  awarded by National Cancer Institute/NIH/DHHS 2014 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2011 - 2016
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2014 - 2016
  • TBCRC017: The Correlation of Radiographic Complete Response on Breast MRI with Pathologic Complete Response in Patients Receiving Neoadjuvant Systemic Treatment  awarded by Johns Hopkins University 2009 - 2015
  • A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer - TBCRC 013 / UAB 0953  awarded by Johns Hopkins University 2009 - 2015
  • Private Grant  awarded by ABBVIE INC 2014 - 2015
  • Targeting Signal Transduction Pathways for the Treatment and Prevention of Breast Cancer  awarded by UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER) 2012 - 2014
  • Private Grant  awarded by Genentech 2007 - 2014
  • Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer  awarded by UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER) 2011 - 2012
  • Full Name

  • Jennifer De Los Santos